FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken-ichi Hiasa

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Anatomy

Tunica Intima

Physiology

Transfection

Co-author Network

Publications

TOP 3
Mizuho Yamada; Kazuyoshi Kuwano; Takashige Maeyama; Michihiro Yoshimi; Naoki Hamada; Jutaro Fukumoto; Kensuke Egashira; Ken-ichi Hiasa; Koichi Takayama; Yoichi Nakanishi
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis.
Naoki Hamada; Kazuyoshi Kuwano; Mizuho Yamada; Naoki Hagimoto; Ken-ichi Hiasa; Kensuke Egashira; Nobutaka Nakashima; Takashige Maeyama; Michihiro Yoshimi; Yoichi Nakanishi
Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice.
Qingwei Zhao; Kensuke Egashira; Ken-ichi Hiasa; Minako Ishibashi; Shujiro Inoue; Kisho Ohtani; Chunyan Tan; Masabumi Shibuya; Akira Takeshita; Kenji Sunagawa
Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken-ichi Hiasa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Mizuho Yamada; Kazuyoshi Kuwano; Takashige Maeyama; Michihiro Yoshimi; Naoki Hamada; Jutaro Fukumoto; Kensuke Egashira; Ken-ichi Hiasa; Koichi Takayama; Yoichi Nakanishi
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis.
Journal of clinical pathology 2007;60(8):916-20.
2005: Naoki Hamada; Kazuyoshi Kuwano; Mizuho Yamada; Naoki Hagimoto; Ken-ichi Hiasa; Kensuke Egashira; Nobutaka Nakashima; Takashige Maeyama; Michihiro Yoshimi; Yoichi Nakanishi
Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):1224-31.
2004: Qingwei Zhao; Kensuke Egashira; Ken-ichi Hiasa; Minako Ishibashi; Shujiro Inoue; Kisho Ohtani; Chunyan Tan; Masabumi Shibuya; Akira Takeshita; Kenji Sunagawa
Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(12):2284-9.
2004: Satoru Tsuruta; Makoto Nakamuta; Munechika Enjoji; Kazuhiro Kotoh; Ken-ichi Hiasa; Kensuke Egashira; Hajime Nawata
Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.
International journal of molecular medicine 2004;14(5):837-42.
2004: Minako Ishibashi; Kensuke Egashira; Qingwei Zhao; Ken-ichi Hiasa; Kisho Ohtani; Yoshiko Ihara; Israel F Charo; Shinobu Kura; Teruhisa Tsuzuki; Akira Takeshita; Kenji Sunagawa
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(11):e174-8.
2004: Kisho Ohtani; Kensuke Egashira; Ken-ichi Hiasa; Qingwei Zhao; Shiro Kitamoto; Minako Ishibashi; Makoto Usui; Shujiro Inoue; Yoshikazu Yonemitsu; Katsuo Sueishi; Masataka Sata; Masabumi Shibuya; Kenji Sunagawa
Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells.
Circulation 2004;110(16):2444-52.
2004: Akio Saiura; Masataka Sata; Ken-ichi Hiasa; Shiro Kitamoto; Miwa Washida; Kensuke Egashira; Ryozo Nagai; Makuuchi Masatoshi
Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(10):1886-90.
2004: Qingwei Zhao; Minako Ishibashi; Ken-ichi Hiasa; Chunyan Tan; Akira Takeshita; Kensuke Egashira
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Hypertension 2004;44(3):264-70.
2004: Ken-ichi Hiasa; Minako Ishibashi; Kisho Ohtani; Shujiro Inoue; Qingwei Zhao; Shiro Kitamoto; Masataka Sata; Toshihiro Ichiki; Akira Takeshita; Kensuke Egashira
Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Circulation 2004;109(20):2454-61.
2004: Minako Ishibashi; Ken-ichi Hiasa; Qingwei Zhao; Shujiro Inoue; Kisho Ohtani; Shiro Kitamoto; Miyuki Tsuchihashi; Takeshi Sugaya; Israel F Charo; Shinobu Kura; Teruhisa Tsuzuki; Tatsuro Ishibashi; Akira Takeshita; Kensuke Egashira
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Circulation research 2004;94(9):1203-10.
2004: Ken-ichi Hiasa; Kensuke Egashira; Shiro Kitamoto; Minako Ishibashi; Shujiro Inoue; Weihua Ni; Qingwei Zhao; Shin Nagata; Makoto Katoh; Masataka Sata; Akira Takeshita
Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor.
Basic research in cardiology 2004;99(3):165-72.
2004: Weihua Ni; Shiro Kitamoto; Minako Ishibashi; Makoto Usui; Shujiro Inoue; Ken-ichi Hiasa; Qingwei Zhao; Ken-ichi Nishida; Akira Takeshita; Kensuke Egashira
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):534-9.
2004: Chu Kataoka; Kensuke Egashira; Minako Ishibashi; Shujiro Inoue; Weihua Ni; Ken-ichi Hiasa; Shiro Kitamoto; Makoto Usui; Akira Takeshita
Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis.
American journal of physiology. Heart and circulatory physiology 2004;286(2):H768-74.
2004: Kisho Ohtani; Kensuke Egashira; Makoto Usui; Minako Ishibashi; Ken-ichi Hiasa; Qingwei Zhao; M Aoki; Yasufumi Kaneda; R Morishita; Akira Takeshita
Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits.
Gene therapy 2004;11(2):126-32.
2002: Shujiro Inoue; Kensuke Egashira; Weihua Ni; Shiro Kitamoto; Makoto Usui; Kisho Otani; Minako Ishibashi; Ken-ichi Hiasa; Ken-ichi Nishida; Akira Takeshita
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Circulation 2002;106(21):2700-6.
2002: Minako Ishibashi; Kensuke Egashira; Ken-ichi Hiasa; Shujiro Inoue; Weihua Ni; Qingwei Zhao; Makoto Usui; Shiro Kitamoto; Toshihiro Ichiki; Akira Takeshita
Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
Hypertension 2002;40(5):687-93.
2002: Makoto Usui; Kensuke Egashira; Kisho Ohtani; Chu Kataoka; Minako Ishibashi; Ken-ichi Hiasa; Makoto Katoh; Qingwei Zhao; Shiro Kitamoto; Akira Takeshita
Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(13):1838-40.